Document Detail

Response to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation.
MedLine Citation:
PMID:  4597119     Owner:  NLM     Status:  MEDLINE    
The bronchodilator and cardiac effects produced by aerosols of 0.5% salbutamol and 0.5% and 1% rimiterol administered for three minutes in 40% oxygen by intermittent positive-pressure ventilation (I.P.P.V.) were compared in 15 asthmatic patients. Salbutamol and both the concentrations of rimiterol were equipotent in peak bronchodilator effect, but salbutamol had a significantly longer duration of bronchodilator action. There was significantly less increase in heart rate after rimiterol than after salbutamol. Aerosols of 0.5% rimiterol, 0.5% salbutamol, and saline were administered by I.P.P.V. to 10 normal volunteers. There was no difference between the mean heart rates after 0.5% rimiterol and saline but a highly significant increase in mean heart rate was observed after 0.5% salbutamol. It was concluded that 0.5% rimiterol was an effective short-acting bronchodilator drug with little or no cardiac beta(1)-adrenergic activity when administered for three minutes by I.P.P.V. in 40% oxygen.
N J Cooke; J A Kerr; R F Willey; M V Hoare; I W Grant; G K Cromptom
Related Documents :
7916759 - Improvements on a design of girdle by using cardiac output and pressure sensation.
21722579 - Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on ...
21587159 - Pressure controlled ventilation to induce acute lung injury in mice.
496229 - Postoperative analgesia using continuous infusion of papaveretum.
7560759 - A causal relationship between fluctuations in thermoregulatory skin perfusion and respi...
14508169 - The icp-lowering effect of 10 degrees reverse trendelenburg position during craniotomy ...
17720979 - Orthostatic hypotension: a new classification system.
3337029 - Blood pressure response to dietary sodium restriction in healthy normotensive children.
15086879 - Abnormal rectal motor physiology in patients with irritable bowel syndrome.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  British medical journal     Volume:  2     ISSN:  0007-1447     ISO Abbreviation:  Br Med J     Publication Date:  1974 May 
Date Detail:
Created Date:  1974-07-12     Completed Date:  1974-07-12     Revised Date:  2010-10-26    
Medline Journal Info:
Nlm Unique ID:  0372673     Medline TA:  Br Med J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  250-2     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuterol / administration & dosage*,  therapeutic use
Asthma / drug therapy*
Beclomethasone / therapeutic use
Bronchodilator Agents / administration & dosage
Heart Rate / drug effects
Middle Aged
Positive-Pressure Respiration*
Prednisolone / therapeutic use
Sympathomimetics / administration & dosage*,  pharmacology,  therapeutic use
Time Factors
Reg. No./Substance:
0/Aerosols; 0/Bronchodilator Agents; 0/Sympathomimetics; 18559-94-9/Albuterol; 4419-39-0/Beclomethasone; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Silver sulfadiazine: effect on the growth and metabolism of bacteria.
Next Document:  Prazosin: preliminary report and comparative studies with other antihypertensive agents.